Tic disorder
Conditions
Interventions
A:The control group was treated with tiapride hydrochloride (Jiangsu Enhua Pharmaceutical Group Co., Ltd., National Drug Approval Number H32025477, 0.1 g × 100 tablets), administered orally, 1–2 table
B:The observation group received Traditional Chinese Medicine Tic Patch treatment on the basis of the control group. Preparation method of the Traditional Chinese Medicine Tic Patch: Coptis chinensis
Sponsors
Shaanxi Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: Meets the Diagnostic Criteria for pediatric tic disorder as outlined in the Pediatric Tic Disorder Diagnosis and Treatment Expert Consensus (2017 Practical Version) [2]; has not received other related treatments within the past month or has discontinued other medications for more than one month; the patient and dependents are informed of the treatment plan and have signed the Informed Consent Form.
Exclusion criteria
Exclusion criteria: History of other mental disorders such as pediatric schizophrenia or chorea; based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Diagnostic Criteria, the child or dependents have cognitive dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of Tic Disorder; | — |
Secondary
| Measure | Time frame |
|---|---|
| the level of Quality of Life; | — |
Countries
China
Contacts
Public ContactQian Niu
Shaanxi Provincial People's Hospital
Outcome results
None listed